Switch theme
Sign up to access all valuation multiples
Dr. Martens PLC is engaged in the business of footwear. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. Geographically, it derives a majority of revenue from EMEA and also has a presence in the Americas and APAC.
2021
2.6K+
LTM Revenue $1.0B
LTM EBITDA $181M
$1.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Dr. Martens has a last 12-month revenue of $1.0B and a last 12-month EBITDA of $181M.
In the most recent fiscal year, Dr. Martens achieved revenue of $1.1B and an EBITDA of $253M.
Dr. Martens expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Dr. Martens valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.1B | XXX | XXX | XXX |
| Gross Profit | $745M | $796M | XXX | XXX | XXX |
| Gross Margin | 58% | 70% | XXX | XXX | XXX |
| EBITDA | $303M | $253M | XXX | XXX | XXX |
| EBITDA Margin | 23% | 22% | XXX | XXX | XXX |
| Net Profit | $233M | $166M | XXX | XXX | XXX |
| Net Margin | 18% | 15% | XXX | XXX | XXX |
| Net Debt | $68.1M | $175M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Dr. Martens's stock price is GBP 1 (or $1).
Dr. Martens has current market cap of GBP 482M (or $621M), and EV of GBP 837M (or $1.1B).
See Dr. Martens trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.1B | $621M | XXX | XXX | XXX | XXX | $0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Dr. Martens has market cap of $621M and EV of $1.1B.
Dr. Martens's trades at 1.0x LTM EV/Revenue multiple, and 6.0x LTM EBITDA.
Analysts estimate Dr. Martens's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Dr. Martens and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.1B | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 5.5x | XXX | XXX | XXX |
| P/E | 15.2x | XXX | XXX | XXX |
| P/E/Growth | 0.4x | XXX | XXX | XXX |
| EV/FCF | 10.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpDr. Martens's NTM/LTM revenue growth is 6%
Dr. Martens's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Dr. Martens's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Dr. Martens's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Dr. Martens and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -12% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -16% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 25% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 51% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Brillia Inc | XXX | XXX | XXX | XXX | XXX | XXX |
| Cettire | XXX | XXX | XXX | XXX | XXX | XXX |
| Merino | XXX | XXX | XXX | XXX | XXX | XXX |
| Premier Investments | XXX | XXX | XXX | XXX | XXX | XXX |
| Step One Clothing | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dr. Martens acquired XXX companies to date.
Last acquisition by Dr. Martens was XXXXXXXX, XXXXX XXXXX XXXXXX . Dr. Martens acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Dr. Martens founded? | Dr. Martens was founded in 2021. |
| Where is Dr. Martens headquartered? | Dr. Martens is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Dr. Martens have? | As of today, Dr. Martens has 2.6K+ employees. |
| Who is the CEO of Dr. Martens? | Dr. Martens's CEO is Mr. Ije Nwokorie. |
| Is Dr. Martens publicy listed? | Yes, Dr. Martens is a public company listed on LON. |
| What is the stock symbol of Dr. Martens? | Dr. Martens trades under DOCS ticker. |
| When did Dr. Martens go public? | Dr. Martens went public in 2021. |
| Who are competitors of Dr. Martens? | Similar companies to Dr. Martens include e.g. Brillia Inc, Cettire, Merino, Premier Investments. |
| What is the current market cap of Dr. Martens? | Dr. Martens's current market cap is $621M |
| What is the current revenue of Dr. Martens? | Dr. Martens's last 12-month revenue is $1.0B. |
| What is the current EBITDA of Dr. Martens? | Dr. Martens's last 12-month EBITDA is $181M. |
| What is the current EV/Revenue multiple of Dr. Martens? | Current revenue multiple of Dr. Martens is 1.0x. |
| What is the current EV/EBITDA multiple of Dr. Martens? | Current EBITDA multiple of Dr. Martens is 6.0x. |
| What is the current revenue growth of Dr. Martens? | Dr. Martens revenue growth between 2023 and 2024 was -12%. |
| Is Dr. Martens profitable? | Yes, Dr. Martens is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
